Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice.

Proceedings of the National Academy of Sciences of the United States of America
Hongmin SunDavid Ginsburg

Abstract

The widespread occurrence of antibiotic resistance among human pathogens is a major public health problem. Conventional antibiotics typically target bacterial killing or growth inhibition, resulting in strong selection for the development of antibiotic resistance. Alternative therapeutic approaches targeting microbial pathogenicity without inhibiting growth might minimize selection for resistant organisms. Compounds inhibiting gene expression of streptokinase (SK), a critical group A streptococcal (GAS) virulence factor, were identified through a high-throughput, growth-based screen on a library of 55,000 small molecules. The lead compound [Center for Chemical Genomics 2979 (CCG-2979)] and an analog (CCG-102487) were confirmed to also inhibit the production of active SK protein. Microarray analysis of GAS grown in the presence of CCG-102487 showed down-regulation of a number of important virulence factors in addition to SK, suggesting disruption of a general virulence gene regulatory network. CCG-2979 and CCG-102487 both enhanced granulocyte phagocytosis and killing of GAS in an in vitro assay, and CCG-2979 also protected mice from GAS-induced mortality in vivo. These data suggest that the class of compounds represented by CCG-...Continue Reading

References

Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J M MusserR K Selander
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D E WexlerP P Cleary
Jan 1, 1983·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·J A Marcum, D L Kline
Jan 25, 1996·The New England Journal of Medicine·A L Bisno, D L Stevens
Mar 1, 1996·Infection·H M HasselhornF W Tiller
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Apr 5, 2002·Microbes and Infection·Dean J HarringtonNeil Chanter
Feb 5, 2003·Drug Discovery Today·Gilbert M Rishton
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Michael GreenEllen R Wald
Jun 25, 2004·The Journal of Biological Chemistry·Paul D BoxrudPaul E Bock
Jul 9, 2004·Veterinary Research·John F Timoney
Oct 29, 2005·The Lancet Infectious Diseases·Jonathan R CarapetisMartin Weber
Jul 6, 2006·Trends in Microbiology·Bernard MartinJean-Pierre Claverys
Dec 26, 2006·Nature Structural & Molecular Biology·Alicia Lammerts van BuerenAlisdair B Boraston
Apr 3, 2007·International Journal of Medical Microbiology : IJMM·Werner Köhler
Jan 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Samuel A ShelburneJames M Musser
Feb 20, 2008·PLoS Pathogens·Shalaka SamantAlexander A Neyfakh
Aug 20, 2008·Cellular Microbiology·Randall J OlsenJames M Musser
May 23, 2009·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Debra E Bessen
Jan 19, 2010·Nature Reviews. Drug Discovery·David A Rasko, Vanessa Sperandio
Sep 17, 2010·Trends in Pharmacological Sciences·Liselotte Diaz HögbergOtto Cars

❮ Previous
Next ❯

Citations

Aug 22, 2012·Extremophiles : Life Under Extreme Conditions·Prashant GabaniOm V Singh
Oct 6, 2012·The Journal of Biological Chemistry·Andrew HollandsVictor Nizet
Jul 16, 2013·PLoS Pathogens·Martina L Sanderson-SmithFrancis J Castellino
Sep 11, 2013·International Journal of Molecular Sciences·Meng ChenHongmin Sun
Jan 1, 2014·Journal of Thrombosis and Thrombolysis·Yuanxi XuHongmin Sun
Oct 21, 2015·Critical Reviews in Microbiology·Marijke PeetermansPeter Verhamme
Oct 30, 2015·Future Medicinal Chemistry·David J Lapinsky, Douglas S Johnson
Jul 21, 2015·Journal of Thrombosis and Haemostasis : JTH·J HawigerJ Zienkiewicz
Jul 8, 2015·Journal of Thrombosis and Haemostasis : JTH·I M VerhammeP E Bock
Aug 11, 2015·The Journal of Clinical Investigation·Luchang ZhuJames M Musser
Oct 14, 2014·Frontiers in Cellular and Infection Microbiology·Torsten G LoofEva Medina
Apr 9, 2017·Applied Biochemistry and Biotechnology·Mervat Morsy Abbas Ahmed El-GendyAhmed M A El-Bondkly
Feb 10, 2017·Molecular & Cellular Proteomics : MCP·Natalie C MarshallChristopher M Overall
Apr 23, 2016·The Journal of Perinatal & Neonatal Nursing·Mary Ellen Burke Sosa
Nov 19, 2014·Infection and Immunity·Rebecca Anthouard, Victor J DiRita
Apr 15, 2015·Antimicrobial Agents and Chemotherapy·Jeremiah G JohnsonVictor J DiRita
Dec 7, 2013·Circulation Research·Susan Ince
Jun 25, 2020·Current Drug Targets·Hongmin SunDavid W Anderson
Jun 11, 2021·Circulation Research·Meaghan E CollingYogendra Kanthi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.